论文信息 - Phase II study of bendamustine, bortezomib and dexamethasone as second-line treatment for elderly patients with multiple myeloma: the Intergroupe Francophone du Myelome 2009-01 trial - 字舞流文

Phase II study of bendamustine, bortezomib and dexamethasone as second-line treatment for elderly patients with multiple myeloma: the Intergroupe Francophone du Myelome 2009-01 trial

B. Pégourié | P. Cony-Makhoul | O. Decaux | P. Moreau | H. Avet-Loiseau | X. Leleu | C. Mathiot | T. Dejoie | H. Jardel | B. Royer | P. Rodon | L. Garderet | O. Fitoussi | M. Roussel | A. Stoppa | C. Chaleteix | M. Tiab | P. Lenain | C. Hulin | L. Benboubker | A. Banos | J. Vilque | B. Anglaret | P. Casassus | M. Petillon | M. Dib | C. Traullé | J. Fontan | B. Kolb | R. Benramdane